STAT News

FEBRUARY 13, 2023

Humira’s main patent expired in 2016, but a byzantine patent saga has kept other drugmakers from offering their own version of the monoclonal antibody used to treat conditions such as rheumatoid arthritis and Crohn’s disease.

Drugs 97

Drugs Pharmacy Antibody Medicine 97

The Pharma Data

JANUARY 12, 2021

million additional doses of the casirivimab and imdevimab antibody cocktail, bringing total potential U.S. Under the new agreement, the government will purchase all finished doses of the casirivimab and imdevimab antibody cocktail delivered by June 30, 2021 , up to 1.25 TARRYTOWN, N.Y. , 12, 2021 /PRNewswire/ — . million doses.

Antibody 52

Antibody Production Manufacturing Clinical Trials 52

The Pharma Data

DECEMBER 29, 2020

First antibody therapy to demonstrate anti-viral effect in patients hospitalized with COVID-19. NASDAQ: REGN) today announced encouraging initial data from an ongoing Phase 1/2/3 clinical trial of the Regeneron antibody cocktail, casirivimab and imdevimab, in hospitalized COVID-19 patients requiring low-flow oxygen. futility analysis).

Antibody 52

Antibody Trials Production Clinical Trials 52

The Pharma Data

DECEMBER 17, 2020

NASDAQ: REGN ) today announced that the New England Journal of Medicine (NEJM) has published initial clinical data from an ongoing seamless Phase 1/2/3 trial of the antibody cocktail casirivimab and imdevimab in non-hospitalized patients with COVID-19. TARRYTOWN, N.Y. , 17, 2020 /PRNewswire/ — Regeneron Pharmaceuticals, Inc.

Antibody 52

Antibody Medicine Production Trials 52

Bioengineer

JULY 23, 2021

The LOTIS-2 trial tested the efficacy of Loncastuximab tesirine, an antibody-drug complex that targets CD19 – the same molecule targeted on the lymphoma B-cells by CAR-T therapy. The state’s leader in obtaining biomedical research funds, in fiscal year 2019, MUSC set a new high, bringing in more than $284 million.

Trials 52

Trials Antibody Drugs Clinical Trials 52

Rethinking Clinical Trials

JANUARY 17, 2024

The first monoclonal antibody (mABs) treatment for treatment of COVID-19 was approved in November 2020. UPMC built upon the success of the Remdesivir lottery and in December 2020, UPMC began infusing monoclonal antibodies across 45 UPMC locations.

Clinical Trials 173

Clinical Trials Clinical Trials Antibody Trials 173

World of DTC Marketing

SEPTEMBER 14, 2021

Even if humoral immunity appears to wane, reductions in neutralizing antibody titre do not necessarily predict reductions in vaccine efficacy over time, and reductions in vaccine efficacy against mild disease do not necessarily predict reductions in the (typically higher) efficacy against severe disease. This is a huge wasted opportunity.

Vaccination 159

Vaccination Vaccine Pharmacy Doctors 159

The Pharma Data

OCTOBER 28, 2020

NASDAQ: REGN) today announced positive, prospective results from an ongoing Phase 2/3 seamless trial in the COVID-19 outpatient setting showing its investigational antibody cocktail, REGN-COV2, met the primary and key secondary endpoints. Regeneron Pharmaceuticals, Inc. Yancopoulos , M.D., President and Chief Scientific Officer of Regeneron.

Antibody 40

Antibody Trials Production Clinical Trials 40

Pharmaceutical Technology

FEBRUARY 24, 2023

Also, it should be expected that AbbVie has and will utilise its relationships with healthcare payers and pharmacy benefit managers (PBMs) to mitigate the losses from the entrance of the adalimumab biosimilar.

Marketing 147

Marketing Development Pharmacy Drugs 147

The Pharma Data

DECEMBER 5, 2020

NASDAQ: REGN) today announced updated data for REGN5458, a BCMAxCD3 bispecific antibody, from the Phase 1 portion of a Phase 1/2 trial in patients with relapsed or refractory (R/R) multiple myeloma. These allow for the creation of bispecific antibodies that closely resemble natural human antibodies with no linkers or artificial sequences.

Antibody 40

Antibody Production Trials Medicine 40

Pharma Mirror

FEBRUARY 11, 2021

In late 2018, National OncoVenture (NOV), a government-funded virtual oncology drug development program in Korea, approached Samsung Biologics for the development of EU101(NOV1801), an anti-4-1BB therapeutic monoclonal antibody provided by Eutilex (KOSDAQ:263050).

Clinical Trials 130

Clinical Trials Clinical Trials Antibody Development 130

Pharmaceutical Technology

MAY 15, 2023

Adeno-associated virus vectors, alcohol dehydrogenase compositions, and antibody serum stabilisers are some of the accelerating innovation areas, where adoption has been steadily increasing. Among maturing innovation areas are anti-influenza antibody compositions and anti-interleukin-1, which are now well established in the industry.

Drugs 130

Drugs DNA Protein Antibody 130

STAT News

NOVEMBER 18, 2022

The monoclonal antibody teplizumab, which will be marketed under the brand name Tzield and is from ProventionBio and Sanofi, is given through intravenous infusion. The first therapy that delays the onset of type 1 diabetes received approval from the U.S. Food and Drug Administration , CNN tells us.

Insulin 98

Insulin FDA Approval Production Pharmacy 98

XTalks

NOVEMBER 30, 2023

SpringWorks is exploring Ogsiveo as a BCMA-targeting agent in combination treatments, including with GSK’s antibody-drug conjugate Blenrep (belantamab mafodotin-blmf), Johnson & Johnson’s T-cell engager Tecvayli (teclistamab-cqyv) and Pfizer’s bispecific Elrexfio (elranatamab-bcmm).

FDA Approval 101

FDA Approval Trials Clinical Trials Clinical Trials 101

XTalks

JANUARY 8, 2024

There, it specifically targets the mucosal B cells in the ileum to inhibit antibody formation. Related: Filspari (Sparsentan) Rare Kidney Disease Drug Gets FDA Approval Availability and Price of Tarpeyo Tarpeyo is available solely through Biologics by McKesson, Calliditas’ specialty pharmacy.

FDA Approval 64

FDA Approval Clinical Trials Clinical Trials Nurses 64

The Pharma Data

AUGUST 21, 2020

Roche and Regeneron join forces to increase global supply of an antibody cocktail for Covid-19. Roche and Regeneron have announced their partnership in the fight to develop, manufacture and distribute REGN-COV2, Regeneron’s investigational anti-viral antibody cocktail, to people around the globe.

Vaccination 52

Vaccination Vaccine Manufacturing Contamination 52

XTalks

SEPTEMBER 22, 2023

Data from clinical and preclinical trials showed that the shots produced antibodies against the variant as well as newer subtypes of it like BA.2.86. They will instead be purchased and paid for by pharmacies and insurers. In June, FDA advisors endorsed updating the shots to target the XBB strain.

Vaccination 59

Vaccination Vaccine FDA Approval Pharmacy 59

Delveinsight

AUGUST 26, 2021

Through the collaboration, the companies focus on connecting clinical trial data with specialty pharmacy information, natural history, registry data, and broad claims databases. Because of difficulty diagnosing those patients, the population is underserved, as per said by the companies. The study is set to conclude in the fall.

Vaccination 98

Vaccination Vaccine Gene Therapy RNA 98

XTalks

NOVEMBER 26, 2020

In addition to innovative new antibody drugs and mRNA vaccines, researchers have found that the sleep-regulating hormone melatonin may also offer protection against COVID-19. The results still require further validation, including experimental and clinical evaluation.

Research 98

Research Hormones Protein Regulation 98

XTalks

MARCH 8, 2024

This means they can be substituted for the reference product at a pharmacy without the need for instruction from a prescriber. Denosumab is a RANKL (receptor activator of nuclear factor kappa beta ligand) monoclonal antibody that blocks the ability of RANKL to bind to its receptor RANK.

Drugs 59

Drugs FDA Approval Production Immune Response 59

The Pharma Data

JANUARY 17, 2021

The treatment is based on the Grifols immunoglobulin Gamunex®-C, and contains anti-SARS-COV-2 polyclonal antibodies from plasma donors who have recovered from COVID-19. And the company supplies tools, information and services that enable hospitals, pharmacies and healthcare professionals to efficiently deliver expert medical care.

Clinical Trials 52

Clinical Trials Clinical Trials Trials Containment 52

The Pharma Data

OCTOBER 30, 2020

NASDAQ: REGN) received today a recommendation from the independent data monitoring committee (IDMC) for the REGN-COV2 antibody cocktail treatment trials for COVID-19 that the current hospitalized patient trial be modified. TARRYTOWN, N.Y. , Regeneron Pharmaceuticals, Inc. Cohort 3: patients on mechanical ventilation.

Production 52

Production Antibody Manufacturing Trials 52

The Pharma Data

AUGUST 8, 2020

Besides benefiting cHL patients, the listing provides a boost to [Tyvyt’s] general accessibility in hospital pharmacies over rivals,” GBI wrote in a recent report. Lilly only holds a stake in Tyvyt, a monoclonal antibody, within China. The national reimbursed price of Tyvyt almost matches that after patient assistance. million ($47.6

Trials 52

Trials Antibody Pharmacy Drugs 52

The Pharma Data

NOVEMBER 20, 2020

NASDAQ: REGN) today announced that the antibody cocktail casirivimab and imdevimab administered together (formerly known as REGN-COV2 or REGEN-COV2), a therapy currently being investigated for use in COVID-19 , has received Emergency Use Authorization (EUA) from the U.S. TARRYTOWN, N.Y., November 21, 2020 – Regeneron Pharmaceuticals, Inc.

Antibody 52

Antibody Production Clinical Trials Clinical Trials 52

XTalks

AUGUST 30, 2022

Such therapies may involve small interfering RNA (siRNA) or oligonucleotides in viral transfection platforms, large molecules and antibodies. What About Small Proteins and Antibodies Reaching Extracellular CNS Targets? All facilities (such as lab, pharmacy, MRI, etc.) The main investigator core team is depicted in the middle.

Trials 83

Trials Drug Delivery Drugs Gene 83

The Pharma Data

NOVEMBER 21, 2020

NASDAQ: REGN) today announced that the antibody cocktail casirivimab and imdevimab administered together (also known as REGN-COV2 or REGEN-COV2), a therapy currently being investigated for use in COVID-19, has received Emergency Use Authorization (EUA) from the U.S. government allocation program. Regeneron Pharmaceuticals, Inc.

Antibody 40

Antibody Production Clinical Trials Clinical Trials 40

XTalks

FEBRUARY 8, 2021

They include proteins, monoclonal antibodies and vaccines that are considered to be “ highly similar ” to biological products that have already been approved by the FDA. What is a Biosimilar? Biosimilars are the “generic” drugs of the biopharma world. What is an Interchangeable Biological Product?

Production 78

Production Insulin Branding Generic Drugs 78

The Pharma Data

MAY 7, 2021

EU regulator begins real-time review of GSK-Vir COVID-19 antibody drug ( Reuters ) ( Press ). Goldman Sachs jumps aboard Bain-backed 503(b) compounding pharmacy with a $275M debt loan to supply hospitals ( Endpoints ). Unused COVID shots piling up in Japan amid slow rollout ( Reuters ).

Vaccination 52

Vaccination Vaccine Drugs Regulation 52

Pharmaceutical Technology

JUNE 9, 2023

The drug performed “extraordinarily well” in a variety of cohorts, said Nimish Patel, PharmD, professor of clinical pharmacy at University of California San Diego. Also known as palivizumab, Sobi ‘s Synagis was the first FDA-approved monoclonal antibody used in children at high risk of RSV disease.

FDA Approval 147

FDA Approval Antibody Allergies Packaging 147

The Pharma Data

NOVEMBER 18, 2020

Eli Lilly and Company’s antibody therapeutic will be distributed as part of the federal government’s Operation Warp Speed. . 18, 2020 /PRNewswire/ — Tampa General Hospital provided the first monoclonal antibody treatment to a COVID-19 positive patient today. TAMPA, Fla., Have diabetes.

Antibody 40

Antibody Medicine Radiology Protein 40

pharmaphorum

MARCH 11, 2021

The UK government’s ongoing door-to-door campaign to contain the new South African variant in parts of London, and the regular launch of reliable antibody tests now being produced at scale, have given the sector an unprecedented prominence. Over a year ago PCR testing was not a familiar term but is now known by general public.

In-Vitro 61

In-Vitro Containment Radiology Life Science 61

The Pharma Data

DECEMBER 3, 2020

Hain will focus on key member touchpoints including care management and navigation, provider and value-based care engagement, pharmacy engagement, health risk assessments, social determinant of health management, and other digital health offerings. Prior to GoHealth, Hain served as CMO for Blue Cross and Blue Shield of Texas.

Development 52

Development Business Development Manufacturing Clinical Development 52

The Pharma Data

NOVEMBER 5, 2020

Lastly, we are proud that our novel antibody cocktail REGN-EB3 recently became the first FDA-approved treatment for Ebola, underscoring the potential of antibody therapies to address deadly infectious diseases.” REGN-COV2 , a dual antibody therapy to SARS-CoV-2 virus. Evinacumab , an antibody to ANGPTL3.

Sales 52

Sales Production Manufacturing Antibody 52

XTalks

JUNE 12, 2023

In addition to dialysis treatments, Fresenius Medical Care offers a range of healthcare services including value and risk-based care programs, pharmacy services and services related to vascular, cardiovascular and endovascular specialties, as well as ambulatory surgery centers.

FDA Approval 98

FDA Approval Production Sales In-Vitro 98

The Pharma Data

NOVEMBER 5, 2020

These statements concern, and these risks and uncertainties include, among others, the impact of SARS-CoV-2 (the virus that has caused the COVID-19 pandemic) on Regeneron’s business and its employees, collaborators, and suppliers and other third parties on which Regeneron relies, Regeneron’s and its collaborators’ ability to continue (..)

Trials 52

Trials Production Clinical Trials Clinical Trials 52

Pharmaceutical Technology

SEPTEMBER 10, 2008

was established in 1999 in the process of privatisation of the State Research Institute for Pharmacy and Biochemistry in the Czech Republic. In the near future, we will add a facility for the production of monoclonal antibodies specifically used in neurological research. Dr Ivana Surovà: Biotest s.r.o.

In-Vitro 130

In-Vitro Genotoxicity In-Vivo Clinical Research 130

XTalks

SEPTEMBER 14, 2020

Moderna, for one, recently reported positive results in older adults between 56 and 71, as well as those 71 years of age and older, who reportedly mounted levels of neutralizing antibodies against the SARS-CoV-2 virus after two doses of its vaccine that were comparable to those seen in younger adults. Johnson & Johnson’s COVID-19 Vaccine.

Vaccination 92

Vaccination Vaccine Antibody Life Science 92